There is currently no “gold standard” test for the diagnosis of late-stage Chagas' disease. As a result, protection of the blood supply in areas where Chagas' disease is endemic remains problematic. A panel of 709 serum samples from subjects with confirmed Chagas' disease ( n = 195), healthy controls ( n = 400), and patients with other parasitic diseases ( n = 114) was used to assess enzyme-linked immunosorbent assays (ELISAs) based on a concentrated extract of excretory-secretory antigens from either Brazil or Tulahuen strain Trypanosoma cruzi trypomastigotes (total trypomastigote excretory-secretory antigens [TESAs]). The total TESA-based assays had excellent overall sensitivity (100%) and specificity (>94%), except for cross-reactivity with Leishmania -infected sera. In an attempt to increase the specificity of the assay, immunoaffinity chromatography was used to purify the TESA proteins (TESA IA proteins). By Western blotting, a series of polypeptide bands with molecular masses ranging from 60 to 220 kDa were recognized by pooled sera positive for Chagas' disease. An ELISA based on TESA IA proteins had a slightly lower sensitivity (98.6%) but an improved specificity (100%) compared to the sensitivity and specificity of the total TESA protein-based ELISAs. A 60-kDa polypeptide was identified as a major contributor to the cross-reactivity with Leishmania . These data suggest the need for field validation studies of TESA- and TESA IA -based assays in regions where Chagas' disease is endemic.
Summary Many serological tests have been developed for the diagnosis of Chagas’ disease, but few have been subjected to a rigorous field evaluation. We have recently described several novel enzyme immunoassays (EIAs) based on fixed‐whole organisms or trypomastigote excretory–secretory antigens (TESA) from different Trypanosoma cruzi strains (Tulahuen or Brazil). This study evaluated the most promising of these novel assays (e.g. fixed‐epimastigotes, fixed‐trypomastigotes, TESA Brazil and TESA Tulahuen antigens) in a field study of Venezuelan blood bank specimens. The assays were tested in an operator‐blinded fashion using 2038 blood bank samples obtained from low and high T.cruzi prevalence regions of Venezuela (n= 1050 and n= 988 from Bolivar and Portuguesa states, respectively). Based on National Laboratory for Chagas Immunodiagnosis (NLCI) ‘gold standard’ results, all novel EIAs were superior to the commercial kit currently used in Venezuela, achieving 100% sensitivity and >99% specificity at optimal cut‐off values. The novel assays identified seven false‐negative samples compared with the routine screening performed by the Venezuelan blood bank although two samples were also misclassified as positive. Minor differences in the performance of the four novel assays were observed at lower arbitrary cut‐off values. This study confirms the potential utility of both the fixed‐organism and the TESA‐based assays in the diagnosis of T.cruzi infection.
Three enzyme immunoassays (EIAs) for diagnosis of Chagas' disease were developed with fixed forms of Trypanosoma cruzi using a panel of 435 sera from the following groups: Venezuelan subjects positive by immunofluorescence ( n = 70), Venezuelan healthy controls ( n = 85), healthy Canadians ( n = 166), and subjects with other parasitic diseases ( n = 114). All assays achieved 100% sensitivity and reasonable specificity for amastigotes (97.6%), epimastigotes (98.3%), and trypomastigotes (99.3%). The fixed-trypomastigote assay was stable over 4 months at 4°C and room temperature. These data suggest that a fixed-trypomastigote EIA may be a suitable candidate for blood bank screening.
El objetivo del presente estudio fue determinar la seroprevalencia de la infección por Trypanosoma cruzi en el estado Sucre (Venezuela) y su asociación con factores de riesgo epidemiológicos. El diseño muestral por conglomerados permitió seleccionar 96 centros poblados y 576 viviendas en los 15 municipios del estado. Asimismo, se evaluaron un total de 2.212 muestras de sueros, a través de las pruebas de ELISA, HAI e IFI. La seroprevalencia en el estado Sucre fue de 3,12%. Los factores de riesgo asociados a la infección por T. cruzi fueron: deposición de basura, materiales predominantes en el piso y paredes, tipo de vivienda, vivir en casas con paredes de bahareque y/o techos de palmas, vivir en casa con paredes y techos de riesgo, construcciones de riesgo y anexos de bahareque, aves dentro de la vivienda y la presencia de leña. La infección se encontró asociada a la edad de los individuos, se detectaron tres casos seropositivos en menores de 15 años. En el estado Sucre existen variables epidemiológicas que favorecen el riesgo a contraer la infección por T. cruzi.